Home > PE Ratio > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of JENBURKT PHARMACEUTICALS is 13.32.

Share Price ₹740.0Apr 25,2024
Market Cap ₹325.6 Cr
Earnings-TTM₹24.4 CrTTM-Standalone Results
Price/Earnings13.32xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of JENBURKT PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of JENBURKT PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹325.6 Cr] as on Apr 25,2024

(/) Earnings [ ₹24.4 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 13.32x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay 13.32 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JENBURKT PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of JENBURKT PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of JENBURKT PHARMACEUTICALS


PE Ratio Performance Analysis for JENBURKT PHARMACEUTICALS

- JENBURKT PHARMACEUTICALS 's latest p/e ratio is 13.32x.

- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 11.24x.

- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 11.66x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 11.94x.

- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 9.81x.


How does JENBURKT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
JENBURKT PHARMACEUTICALS 24.4513.32325.6
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.54364,831.0
CIPLA LTD3,744.0330.31113,471.0
DR REDDYS LABORATORIES LTD5,209.4019.91103,713.0
ZYDUS LIFESCIENCES LTD2,954.2032.3995,687.8
DIVIS LABORATORIES LTD1,382.9773.73101,960.0
MANKIND PHARMA LTD1,743.3055.1296,093.1
TORRENT PHARMACEUTICALS LTD1,494.0060.9991,124.7
LUPIN LTD1,809.7440.1672,687.6
AUROBINDO PHARMA LTD2,777.8923.2864,661.3
ABBOTT INDIA LTD1,145.5847.6054,533.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JENBURKT PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 13.32x
Max industry PE 73.73x
Median industry PE 40.16x
Average industry PE 39.76x



You may also like the below Video Courses